The condition of a Taiwanese businessman who contracted the H7N9 avian influenza virus in China has improved to the point where he has been taken off his ventilator, and may soon be moved to a normal ward, National Taiwan University Hospital (NTUH) said on Tuesday.
“The patient has been taken off a ventilator, is no longer testing positive for the virus and has been taken off the anti-flu drug Tamiflu,” NTUH deputy superintendent Chang Shan-chwen (張上淳) said.
“If all goes well, the patient can be transferred to a normal ward in the next couple of days for continued treatment and recuperation,” Chang added.
The 53-year-old man, identified only by his surname, Lee (李), has been receiving intensive treatment in a negative pressure quarantine ward since April 20 after testing positive for the H7N9 virus following his return to Taiwan on April 9.
At the most serious stage of his illness, Lee was put on a ventilator and given extracorporeal membrane oxygenation (ECMO) therapy. He was taken off the ECMO, a machine that functions as an artificial lung, on Thursday last week.
“While the patient is clearly conscious and his health is improving steadily, he nevertheless remains weak and still suffers shortness of breath,” Chang said at a media briefing, with the consent of the patient’s family.
“It is still not clear when Lee can be discharged,” he added.
The H7N9 strain of bird flu had not been found in humans until cases were reported in China in April.
Scientists in China and other countries said the virus has jumped from birds, most probably chickens, to humans.
The virus has so far infected at least 129 people in China and killed 31 of them, according to the latest data from China’s health authorities and the WHO. To date, Taiwan is the only place outside China that has reported a case of H7N9.
Chang said that a sample of the virus obtained from Lee is likely to be used for virological study to analyze its genetic makeup, clinical symptoms and effectiveness of drug treatments.
A report from the Reuters news agency on Tuesday said that the WHO and the US Centers for Disease Control and Prevention have prepared samples of the virus to give to manufacturers for vaccine production.
New cell-culture technology developed by Novartis AG has reduced the production timeline for vaccines to a matter of weeks, although human safety trials will still require several months, the report said.
Major flu vaccine manufacturers include Sanofi SA, GlaxoSmithKline PLC, Novartis, Australia’s CSL Ltd, Baxter International Inc and AstraZeneca PLC, the report said.
The two main drugs that appear to be effective against H7N9 are Roche Holding AG’s Tamiflu and GlaxoSmithKline’s Relenza, the report added.
Death row inmate Huang Lin-kai (黃麟凱), who was convicted for the double murder of his former girlfriend and her mother, is to be executed at the Taipei Detention Center tonight, the Ministry of Justice announced. Huang, who was a military conscript at the time, was convicted for the rape and murder of his ex-girlfriend, surnamed Wang (王), and the murder of her mother, after breaking into their home on Oct. 1, 2013. Prosecutors cited anger over the breakup and a dispute about money as the motives behind the double homicide. This is the first time that Minister of Justice Cheng Ming-chien (鄭銘謙) has
BITTERLY COLD: The inauguration ceremony for US president-elect Donald Trump has been moved indoors due to cold weather, with the new venue lacking capacity A delegation of cross-party lawmakers from Taiwan, led by Legislative Speaker Han Kuo-yu (韓國瑜), for the inauguration of US president-elect Donald Trump, would not be able to attend the ceremony, as it is being moved indoors due to forecasts of intense cold weather in Washington tomorrow. The inauguration ceremony for Trump and US vice president-elect JD Vance is to be held inside the Capitol Rotunda, which has a capacity of about 2,000 people. A person familiar with the issue yesterday said although the outdoor inauguration ceremony has been relocated, Taiwan’s legislative delegation has decided to head off to Washington as scheduled. The delegation
TRANSPORT CONVENIENCE: The new ticket gates would accept a variety of mobile payment methods, and buses would be installed with QR code readers for ease of use New ticketing gates for the Taipei metro system are expected to begin service in October, allowing users to swipe with cellphones and select credit cards partnered with Taipei Rapid Transit Corp (TRTC), the company said on Tuesday. TRTC said its gates in use are experiencing difficulty due to their age, as they were first installed in 2007. Maintenance is increasingly expensive and challenging as the manufacturing of components is halted or becoming harder to find, the company said. Currently, the gates only accept EasyCard, iPass and electronic icash tickets, or one-time-use tickets purchased at kiosks, the company said. Since 2023, the company said it
Another wave of cold air would affect Taiwan starting from Friday and could evolve into a continental cold mass, the Central Weather Administration (CWA) said yesterday. Temperatures could drop below 10°C across Taiwan on Monday and Tuesday next week, CWA forecaster Chang Chun-yao (張竣堯) said. Seasonal northeasterly winds could bring rain, he said. Meanwhile, due to the continental cold mass and radiative cooling, it would be cold in northern and northeastern Taiwan today and tomorrow, according to the CWA. From last night to this morning, temperatures could drop below 10°C in northern Taiwan, it said. A thin coat of snow
RSS